¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : º¤ÅÍ À¯Çüº°, ¿öÅ©Ç÷ο캰, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Viral Vector Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vector Type, By Workflow, By Application, By End User, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1763843
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,236,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,621,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,086,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ¼¼°è ½ÃÀåÀº 2024³â¿¡ 67¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2030³â¿¡´Â 159¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 15.45%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶´Â Ä¡·á ¶Ç´Â ¿¬±¸ ¸ñÀûÀ¸·Î Ç¥Àû ¼¼Æ÷¿¡ À¯Àü ¹°ÁúÀ» Àü´ÞÇϱâ À§ÇÑ ¿î¹Ýü·Î »ç¿ëµÇ´Â Àΰø ¹ÙÀÌ·¯½ºÀÇ °³¹ßÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¤ÅÍ´Â À¯ÀüÀÚ Ä¡·á, À¯ÀüÀÚ ÆíÁý, ¹é½Å °³¹ß¿¡ µµ¿òÀÌ µÇ°í ÀÖÀ¸¸ç, À¯ÀüÀÚ Áúȯ ¹× ¾Ï Ä¡·á¿¡ Á¤È®¼ºÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ °úÁ¤¿¡´Â º´¿ø¼ºÀ» Á¦°ÅÇϰí Ä¡·á À¯ÀüÀÚ¸¦ »ðÀÔÇϱâ À§ÇØ ¹ÙÀÌ·¯½º À¯Àüü¸¦ º¯ÇüÇÏ´Â °úÁ¤ÀÌ Æ÷ÇԵ˴ϴÙ. ÁÖ¿ä ¹ÙÀÌ·¯½º º¤ÅÍ¿¡´Â ¾Æµ¥³ë ºÎ¼Ó ¹ÙÀÌ·¯½º(AAV), ·»Æ¼¹ÙÀÌ·¯½º, ¾Æµ¥³ë¹ÙÀÌ·¯½º, ¾Æµ¥³ë¹ÙÀÌ·¯½º, ·¹Æ®·Î¹ÙÀÌ·¯½º µîÀÌ ÀÖÀ¸¸ç, °¢°¢ ÀǵµµÈ ¿ëµµ, Ç¥Àû ¼¼Æ÷ÀÇ Á¾·ù, ÇÊ¿äÇÑ ¹ßÇö ÇÁ·ÎÆÄÀÏ¿¡ µû¶ó ¼±Åõ˴ϴÙ. ½ÂÀÎµÈ À¯ÀüÀÚ Ä¡·áÁ¦ÀÇ ¼º°ø°ú R&D ÅõÀÚ Áõ°¡´Â °íǰÁúÀÇ È®Àå °¡´ÉÇÑ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¡¼ÓÈ­ÇÏ¿© ÀÌ ºÐ¾ßÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 67¾ï 1,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 159¾ï 2,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 15.45%
±Þ¼ºÀå ºÎ¹® ¾Æµ¥³ë ºÎ¼Ó ¹ÙÀÌ·¯½º º¤ÅÍ
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

¹ÙÀÌ·¯½º º¤ÅÍ »ý»êÀÇ ¼±±¸ÀûÀÎ ÀÓ»óÀû ¼º°ø

ÁÖ¿ä ½ÃÀå °úÁ¦

È®À强°ú »ó¾÷È­

ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦Á¶ °øÁ¤ ÃÖÀûÈ­

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå PESTEL ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Viral Vector Production Market was valued at USD 6.71 billion in 2024 and is anticipated to reach USD 15.92 billion by 2030, growing at a CAGR of 15.45% during the forecast period. Viral vector production involves the development of engineered viruses used as carriers to deliver genetic material into targeted cells for therapeutic or research purposes. These vectors are instrumental in gene therapy, gene editing, and vaccine development, offering precision in treating genetic disorders and cancers. The process entails modifying viral genomes to eliminate pathogenic properties and incorporate therapeutic genes. Key viral vectors include adeno-associated viruses (AAV), lentiviruses, adenoviruses, and retroviruses, each selected based on the intended application, target cell type, and required expression profile. The growing success of approved gene therapies and increasing R&D investments are accelerating demand for high-quality, scalable viral vector manufacturing, driving significant growth in this segment.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.71 Billion
Market Size 2030USD 15.92 Billion
CAGR 2025-203015.45%
Fastest Growing SegmentAdeno-Associated Virus Vectors
Largest MarketNorth America

Key Market Drivers

Pioneering Clinical Success of Viral Vector Production

The clinical success of gene therapies leveraging viral vectors has played a critical role in driving market growth. Breakthroughs such as Luxturna, approved by the FDA for treating Leber congenital amaurosis (LCA), and Zolgensma for spinal muscular atrophy (SMA), underscore the transformative potential of viral vector-based treatments. Zolgensma alone has treated over 3,000 patients globally as of 2023. Additionally, promising advancements in hemophilia B treatments, utilizing AAV vectors to restore clotting factor IX levels, highlight the clinical viability of these delivery tools. Lentiviral vectors have also been widely adopted in CAR-T cell therapies targeting blood cancers. These successes demonstrate the therapeutic efficacy, safety, and long-term benefits of viral vectors, prompting increased investment and adoption across both academic and commercial sectors.

Key Market Challenges

Scalability and Commercialization

Scaling up viral vector production for commercial use poses significant operational and financial hurdles. Transitioning from lab-scale to large-scale manufacturing requires overcoming challenges such as maintaining yield consistency, optimizing cell culture conditions, and controlling vector integrity under scaled processes. High-yield production must address issues related to oxygen transfer, nutrient delivery, and shear stress in bioreactors. Additionally, ensuring quality and stability of viral vectors during purification and fill-finish steps is essential but complex. Building compliant manufacturing facilities requires large capital investment and adherence to strict regulatory standards. These scale-related constraints delay commercialization timelines, increase production costs, and limit patient access to advanced therapies, especially when demand accelerates.

Key Market Trends

Manufacturing Process Optimization

Process optimization is a critical trend shaping the viral vector production landscape. Industry players are focusing on increasing yield, consistency, and scalability through innovations in upstream and downstream workflows. Efforts include enhancing cell line productivity, refining transfection protocols, and automating quality control. Manufacturers are standardizing production processes to ensure reproducibility across facilities, which aids in regulatory compliance and technology transfer. Moreover, improvements in purification and fill-finish steps are helping reduce impurities and boost product quality. Environmentally sustainable manufacturing approaches-such as reducing waste and energy usage-are also gaining prominence. These optimizations not only lower production costs but also ensure that therapies reach patients more efficiently and reliably.

Key Market Players

Report Scope:

In this report, the Global Viral Vector Production Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Viral Vector Production Market, By Vector Type:

Viral Vector Production Market, By Workflow:

Viral Vector Production Market, By Application:

Viral Vector Production Market, By End User:

Viral Vector Production Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Viral Vector Production Market.

Available Customizations:

Global Viral Vector Production Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Viral Vector Production Market Outlook

6. North America Viral Vector Production Market Outlook

7. Europe Viral Vector Production Market Outlook

8. Asia-Pacific Viral Vector Production Market Outlook

9. South America Viral Vector Production Market Outlook

10. Middle East and Africa Viral Vector Production Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â